TY - JOUR
T1 - ASTRO Journals' Data Sharing Policy and Recommended Best Practices
AU - Tegbaru, Dawit
AU - Braverman, Lisa
AU - Zietman, Anthony L.
AU - Yom, Sue S.
AU - Lee, W. Robert
AU - Miller, Robert C.
AU - Jackson, Isabel L.
AU - McNutt, Todd
AU - Dekker, Andre
N1 - Funding Information:
Disclosures: Mr Tegbaru reports salary from ASTRO and holding the position of Managing Editor of Practical Radiation Oncology and Advances in Radiation Oncology. Ms Braverman reports a salary from ASTRO and holding the position of Managing Editor at the Red Journal. Dr Zietman reports honorarium from ASTRO as Editor-in-Chief of the International Journal of Radiation Oncology Biology Physics. Dr Yom reports grants from Genentech, grants from Merck, grants from Bristol-Myers Squibb, personal fees from Galera, personal fees from UpToDate, personal fees from Springer, grants from Biomimetix, outside the submitted work. Dr Miller reports honorarium fees from ASTRO as Editor-in-Chief of Advances in Radiation Oncology. Dr Jackson reports relationships with Humanetics Corporation, Scientific Advisory Board (current); ConverGene, grant writer, consultant (2017); Riptide Biosciences, grant writer, consultant (2017). Dr McNutt reports other (founder) from Oncospace Inc, grants from Canon Medical Systems, outside the submitted work. Dr Dekker reports other (founder and shareholder) from Medical Data Works BV, grants and personal fees from Varian Medical Systems, grants from Philips Health care, grants from Sohard GmbH, outside the submitted work.
Funding Information:
Sources of support: This work had no specific funding. Disclosures: Mr Tegbaru reports salary from ASTRO and holding the position of Managing Editor of Practical Radiation Oncology and Advances in Radiation Oncology. Ms Braverman reports a salary from ASTRO and holding the position of Managing Editor at the Red Journal. Dr Zietman reports honorarium from ASTRO as Editor-in-Chief of the International Journal of Radiation Oncology Biology Physics. Dr Yom reports grants from Genentech, grants from Merck, grants from Bristol-Myers Squibb, personal fees from Galera, personal fees from UpToDate, personal fees from Springer, grants from Biomimetix, outside the submitted work. Dr Miller reports honorarium fees from ASTRO as Editor-in-Chief of Advances in Radiation Oncology. Dr Jackson reports relationships with Humanetics Corporation, Scientific Advisory Board (current); ConverGene, grant writer, consultant (2017); Riptide Biosciences, grant writer, consultant (2017). Dr McNutt reports other (founder) from Oncospace Inc, grants from Canon Medical Systems, outside the submitted work. Dr Dekker reports other (founder and shareholder) from Medical Data Works BV, grants and personal fees from Varian Medical Systems, grants from Philips Health care, grants from Sohard GmbH, outside the submitted work.
Publisher Copyright:
© 2019 The Author(s)
PY - 2019
Y1 - 2019
N2 - Transparency, openness, and reproducibility are important characteristics in scientific publishing. Although many researchers embrace these characteristics, data sharing has yet to become common practice. Nevertheless, data sharing is becoming an increasingly important topic among societies, publishers, researchers, patient advocates, and funders, especially as it pertains to data from clinical trials. In response, ASTRO developed a data policy and guide to best practices for authors submitting to its journals. ASTRO's data sharing policy is that authors should indicate, in data availability statements, if the data are being shared and if so, how the data may be accessed. (C) 2019 The Author(s). Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.
AB - Transparency, openness, and reproducibility are important characteristics in scientific publishing. Although many researchers embrace these characteristics, data sharing has yet to become common practice. Nevertheless, data sharing is becoming an increasingly important topic among societies, publishers, researchers, patient advocates, and funders, especially as it pertains to data from clinical trials. In response, ASTRO developed a data policy and guide to best practices for authors submitting to its journals. ASTRO's data sharing policy is that authors should indicate, in data availability statements, if the data are being shared and if so, how the data may be accessed. (C) 2019 The Author(s). Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.
U2 - 10.1016/j.adro.2019.08.002
DO - 10.1016/j.adro.2019.08.002
M3 - Article
C2 - 31673648
SN - 2452-1094
VL - 4
SP - 551
EP - 558
JO - Advances in Radiation Oncology
JF - Advances in Radiation Oncology
IS - 4
ER -